Product Description: Anticancer agent 210 (Compound 7a) is a Gefitinib (HY-50895) derivative. Anticancer agent 210 inhibits proliferation, migration and colony formation of cancer cells. Anticancer agent 210 induces apoptosis in cells H1299[1].
Formula: C31H31BrFN7O3
References: [1]Gao E, et al., Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation. Sci Rep. 2024 Apr 22;14(1):9223.
Molecular Weight: 648.53
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Apoptosis